subperiosteal implants
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response
- 11 March 2025
- Posted by: anjaform
- Category: In Vitro Studies
Roberto Campagna, Valentina Schiavoni, Loredana Rao, Fabrizio Bambini, Andrea Frontini, Francesco Sampalmieri, Eleonora Salvolini, Lucia Memé
Full text link: https://pubmed.ncbi.nlm.nih.gov/40141517/
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response
1. Scientific Reference
- Study Title: Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response
- Authors: Roberto Campagna, Valentina Schiavoni, Loredana Rao, Fabrizio Bambini, Andrea Frontini, Francesco Sampalmieri, Eleonora Salvolini, Lucia Memé
- Journal: Materials
- Year of Publication: 2025
- DOI: 10.3390/ma18061234
2. Scientific Background
The management of severe jawbone atrophy remains one of the most demanding challenges in implant dentistry. Although endosseous implants represent the standard of care for oral rehabilitation, adequate bone volume is essential to achieve predictable osseointegration. In patients with extensive alveolar bone loss, conventional implant placement may not be feasible without complex regenerative procedures.
Recent advances in digital implant planning, cone beam computed tomography (CBCT), computer-aided design, and additive manufacturing have renewed interest in patient-specific subperiosteal implants. Unlike historical subperiosteal frameworks, modern titanium devices are digitally designed to closely match the patient’s anatomical morphology, improving their mechanical adaptation while reducing manufacturing inaccuracies.
As implant design has evolved, increasing attention has shifted toward optimizing the biological interaction between titanium surfaces and surrounding tissues. Surface microtopography plays a central role in the early stages of bone healing by influencing osteoblast adhesion, proliferation, and differentiation. Within this context, the present study investigates whether different surface treatments applied to Ti6Al4V alloy can enhance the biological response of osteoblast-like cells, providing experimental evidence that may contribute to the future development of customized subperiosteal implant systems.
3. Study Objective
The primary objective of this investigation was to evaluate the biological effects of five different Ti6Al4V surface treatments on a human osteoblast-like cell line (MG-63).
More specifically, the authors sought to determine whether a newly developed surface treatment designed for customized subperiosteal dental implants could improve cellular proliferation and promote osteogenic activity when compared with untreated titanium surfaces and other commonly used surface modifications.
4. Methodology
This research was conducted as an in vitro preclinical study.
MG-63 human osteoblast-like cells were cultured directly on grade 5 Ti6Al4V discs measuring 10 mm in diameter. Five surface conditions were investigated: an untreated control surface (CTRL), electrical discharge machining (EE), sandblasting combined with acid etching (ES), a novel proprietary surface treatment developed by Al Ti Color (ATcs), and color anodization (CA).
Surface morphology was first characterized using scanning electron microscopy (SEM). Biological performance was subsequently evaluated through complementary laboratory analyses, including MTT assays to assess cell proliferation over a 72-hour period, confocal fluorescence microscopy to examine cell adhesion and distribution, quantitative analysis of Ki-67 expression as a proliferation marker, and real-time PCR profiling of 84 genes involved in osteogenic differentiation.
Statistical comparisons among experimental groups were performed using one-way ANOVA, with statistical significance defined as p < 0.05.
5. Main Findings
Scanning electron microscopy confirmed that each surface treatment generated a distinct microtopography. The untreated control disc displayed a relatively rough surface, whereas the electrical discharge machining (EE) treatment produced irregular depressions of varying size and depth. The sandblasted and acid-etched (ES) surface exhibited a characteristic microrough architecture, while the novel ATcs treatment demonstrated a comparable macroscopic appearance but revealed superficial microporosities at higher magnification. The color-anodized (CA) surface showed an irregular pattern containing both circular and longitudinal depressions. These observations confirmed that each manufacturing process created a unique surface morphology capable of influencing subsequent cellular behavior.
Cell proliferation assays demonstrated that biological responses varied considerably according to surface treatment. Among the evaluated surfaces, the ES treatment significantly increased MG-63 cell proliferation after 48 and 72 hours compared with the untreated control. Conversely, both EE and CA surfaces significantly reduced cellular proliferation after 72 hours. The ATcs surface did not produce a statistically significant increase in proliferation relative to the control. These findings were supported by Ki-67 gene expression analysis, which showed reduced proliferative activity on EE and CA surfaces, whereas ES and ATcs exhibited expression levels comparable to the untreated titanium discs.
Confocal fluorescence microscopy further corroborated these observations. The ES surface demonstrated the highest density of adherent MG-63 cells after 72 hours, indicating enhanced colonization of the titanium substrate. Cell density on the ATcs discs remained similar to that observed on untreated titanium, while EE and CA surfaces showed noticeably fewer adherent cells.
Gene expression profiling revealed that each surface modification induced a distinct osteogenic transcriptional signature. The ES treatment upregulated numerous genes associated with osteoblast differentiation and bone formation. The ATcs surface also stimulated the expression of several genes involved in osteogenic signaling pathways, including factors related to growth regulation, cell adhesion, and bone metabolism. Although ATcs did not enhance cellular proliferation, the authors interpreted its molecular profile as evidence of a favorable osteogenic response. They conclude that this novel surface treatment may contribute to improving the biological stabilization of subperiosteal implants by promoting osteogenic activity, while emphasizing that these findings remain limited to an in vitro experimental model and require validation in future in vivo studies.
6. Clinical Analysis
This study highlights an important aspect of implant design that often receives less attention than implant geometry or digital customization: the biological influence of titanium surface characteristics. While modern subperiosteal implants benefit from highly accurate CAD/CAM workflows and additive manufacturing technologies, their long-term performance also depends on the quality of the biological interface established between the implant and the surrounding bone.
The findings demonstrate that different surface treatments do not necessarily promote the same biological mechanisms. The ES surface primarily enhanced osteoblast proliferation and early cell colonization, suggesting favorable conditions for initial cellular expansion. In contrast, the novel ATcs treatment exhibited a different biological profile. Rather than increasing cell proliferation, it appeared to stimulate the expression of genes involved in osteogenic differentiation and bone-forming pathways. This distinction is clinically relevant because successful osseointegration depends not only on the number of adherent cells but also on their capacity to mature into functional bone-forming cells.
From an implantology perspective, these results suggest that future surface engineering strategies may benefit from targeting osteogenic differentiation in addition to maximizing early cellular proliferation. Such an approach could be particularly valuable for customized subperiosteal implants, where biological integration with the residual bone is critical for long-term stability.
Nevertheless, the clinical implications should be interpreted cautiously. The investigation was performed exclusively using the MG-63 osteoblast-like cell line under controlled laboratory conditions. Cellular behavior observed in vitro cannot fully reproduce the complex biological environment encountered in patients, where vascularization, immune responses, mechanical loading, and bone remodeling collectively influence implant healing. Moreover, the study provides no clinical outcomes regarding implant survival, mechanical stability, peri-implant tissue response, or long-term osseointegration.
Consequently, while the biological data are encouraging, they should be viewed as preliminary preclinical evidence rather than confirmation of clinical superiority. Additional animal studies and well-designed clinical investigations will be necessary before these surface modifications can be considered to improve treatment outcomes in implant dentistry.
7. Clinical Applications
The findings of this study are particularly relevant to the ongoing development of patient-specific subperiosteal dental implants manufactured through additive manufacturing technologies. Although the investigation was conducted under laboratory conditions, it provides valuable biological insights into how titanium surface engineering may influence the earliest phases of bone healing.
The evaluated surface treatments may be especially applicable in situations involving severe alveolar bone atrophy, where conventional endosseous implant placement is not feasible without extensive bone augmentation. In these challenging clinical scenarios, customized subperiosteal implants have re-emerged as a treatment option supported by digital workflows, including CBCT imaging, computer-assisted design (CAD), and laser melting technologies.
The study also highlights the potential importance of selecting surface treatments capable of promoting osteogenic activity rather than simply enhancing cellular proliferation. Such an approach could contribute to improving the biological interaction between customized titanium frameworks and residual bone.
However, these observations should not be interpreted as evidence of improved clinical performance. The study does not evaluate implant survival, osseointegration success rates, mechanical stability, or long-term patient outcomes. Consequently, any clinical application remains speculative until supported by animal models and prospective clinical investigations.
8. Level of Evidence, Limitations, and Transparency
This publication represents an in vitro preclinical investigation, which provides a relatively low level of clinical evidence despite offering valuable mechanistic information regarding osteoblast behavior on modified titanium surfaces.
Several methodological limitations should be considered when interpreting the findings. The experiments were performed exclusively using the MG-63 osteoblast-like cell line under controlled laboratory conditions. Although widely used in biomaterials research, this experimental model cannot fully reproduce the biological complexity of human bone healing, including vascularization, immune regulation, mechanical loading, and tissue remodeling.
Furthermore, the study contains no animal experiments or clinical validation. Implant survival, peri-implant tissue response, long-term osseointegration, and prosthetic outcomes were not evaluated. The authors explicitly acknowledge that additional in vivo studies are required before translating these observations into clinical practice.
Regarding transparency, the titanium discs were manufactured by New Ancorvis S.r.l., while the various surface treatments were performed by Al Ti Color S.r.l. The investigators state that they remained blinded to the identity of each surface treatment until completion of the experimental analyses. Based on the information available in the article, no explicit conflicts of interest related to the study findings are reported.
9. Key Study Highlights
- Study Design: In vitro preclinical study.
- Level of Evidence: Preclinical laboratory research.
- Study Model: Human osteoblast-like MG-63 cell line.
- Number of Patients: Not applicable.
- Number of Implants: Not specified in the available data (five Ti6Al4V surface conditions were evaluated).
- Follow-up Period: Up to 72 hours of cell culture.
- Primary Outcome: Influence of different Ti6Al4V surface treatments on osteoblast proliferation and osteogenic gene expression.
- Methods: Scanning electron microscopy (SEM), MTT proliferation assay, confocal fluorescence microscopy, Ki-67 gene expression, and real-time PCR analysis of 84 osteogenesis-related genes.
- Main Finding: The sandblasted and acid-etched (ES) surface significantly enhanced cell proliferation, whereas the novel ATcs surface induced a favorable osteogenic gene expression profile without significantly increasing proliferation.
- Scientific Conclusion: The newly developed ATcs surface may promote biological mechanisms associated with osteogenesis and potentially improve the stabilization of customized subperiosteal implants. Further in vivo validation is required.
- Main Limitations: Cell culture model only; no animal or clinical validation; no long-term biological or clinical outcomes.
10. Scientific Impact
This study contributes to the growing body of research supporting the modernization of subperiosteal implant therapy through digital manufacturing technologies and advanced biomaterial engineering. Rather than focusing solely on implant geometry or manufacturing precision, the authors investigate how surface modifications can influence the biological events occurring immediately after implant placement.
One of the most significant contributions of this work is the demonstration that different titanium surface treatments may promote distinct biological responses. Increased cellular proliferation and enhanced osteogenic differentiation should not be regarded as interchangeable outcomes, as they represent different phases of bone healing. By distinguishing these mechanisms, the study encourages a more sophisticated approach to implant surface optimization.
Although the investigation does not establish clinical superiority for any particular treatment, it provides valuable experimental evidence supporting further development of bioactive surface technologies for customized subperiosteal implants. These findings may help guide future translational research, including animal studies and prospective clinical trials designed to determine whether the observed molecular responses translate into improved osseointegration and long-term implant stability in patients.
11. Editorial Conclusion
This preclinical investigation provides meaningful insight into the biological influence of Ti6Al4V surface engineering for customized subperiosteal dental implants. While the sandblasted and acid-etched surface demonstrated the strongest effect on osteoblast proliferation, the newly developed ATcs treatment showed a distinctive capacity to stimulate osteogenic gene expression, suggesting a potentially favorable biological profile for early bone integration. Because these findings originate from an in vitro experimental model, they should be interpreted cautiously. Nevertheless, the study establishes a solid scientific foundation for future translational research aimed at optimizing implant surface technologies for the rehabilitation of patients with severe alveolar bone deficiency.
